Logo.png
Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight
22 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Short Bowel Syndrome Market Size and Share is Anticipated to Surge During the Study Period (2020–2034) | DelveInsight   The dynamics of the short...
zealand_logo_RGB_01.png
Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
22 déc. 2023 04h30 HE | Zealand Pharma
Press release – No. 18 / 2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome Copenhagen, Denmark, December 22, 2023 – Zealand Pharma A/S...
zealand_logo_RGB_01.png
Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference
12 avr. 2023 11h00 HE | Zealand Pharma
Press release – No. 2 / 2023 Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference Copenhagen, Denmark, April 12, 2023 – Zealand Pharma A/S (Nasdaq...
FBI LOGO TM.png
With 14.4% CAGR, Short Bowel Syndrome Market Size to Surpass Around USD 2,213.5 Billion by 2029
19 déc. 2022 06h48 HE | Fortune Business Insights
Pune, India, Dec. 19, 2022 (GLOBE NEWSWIRE) -- The short bowel syndrome market size was valued at USD 737.9 million in 2021. It is projected to reach from USD 865.3 million in 2022 to USD 2,213.5...
VectivBio_Logo_RGB_Color.png
VectivBio Appoints Patrick Malloy as Senior Vice President, Investor Relations & Strategic Communications
21 avr. 2022 07h15 HE | VectivBio AG
BASEL, Switzerland, April 21, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
VectivBio_Logo_RGB_Color.png
VectivBio Announces Third Quarter 2021 Business Update
10 nov. 2021 08h30 HE | VectivBio AG
-Pivotal STARS Program of Apraglutide in SBS-IF Progressing with Majority of Sites Activated and Screening; STARS Nutrition Interim Results Expected 1H 2022- -Expanded Rare Disease Pipeline with...
VectivBio_Logo_RGB_Color.png
VectivBio Publishes Invitation to the Extraordinary General Meeting
12 août 2021 07h15 HE | VectivBio AG
BASEL, Switzerland, Aug. 12, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on the discovery, development and...
VectivBio_Logo_RGB_Color.png
VectivBio Nominates Paul R. Carter and Murray W. Stewart for Election to its Board of Directors
12 juil. 2021 07h15 HE | VectivBio AG
- Industry veterans bring decades of clinical, regulatory and commercial management expertise to VectivBio - - Nominees will stand for election at an Extraordinary General Meeting of shareholders on...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma introduces new website to support people living with short bowel syndrome
21 juin 2019 03h00 HE | Zealand Pharma
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome LivingWithSBS.com is a new website with information about short bowel syndrome,...